British American Tobacco (NYSE: BTI), one of the leading global tobacco companies, is well diversified, both geographically and across its product portfolio.
It owns traditional cigarette brands like Camel and Newport, as well as next-gen products like Vuse vapes and Velo nicotine pouches. Like most of its peers in the tobacco industry, British American Tobacco is known for its high dividend yield, currently at 8.5%.
Tobacco stocks went on a tear earlier this year, seemingly as dividend-hungry investors moved into the sector ahead of expected interest rate cuts. Over the last month, however, the stock has pulled back, and one analyst believes the stock has further to fall.
In a recent note, Morgan Stanley gave British American Tobacco a double downgrade, lowering its rating on the stock from overweight (buy) to underweight (sell). The investment bank said the company was at risk due to an inability to enforce regulations against flavored disposable e-cigarettes in the U.S., echoing concerns from CEO Tadeu Marroco.
Morgan Stanley predicted that competition from illegal vaping products in the U.S. would weigh on the business, forecasting a low-single-digit decline in U.S. sales in fiscal 2025 and 2026.
It gave the stock a price target of $33.
Many investors own the stock for the dividend while understanding that tobacco companies are grappling with strong industry headwinds.
And British American Tobacco looks cheap at a price-to-earnings ratio of 6.3, but that's to be expected for a company with declining demand for its core product. Organic revenue was down 0.8% year over year, and revenue from new categories was up just 7.4%. Vape volumes were down 9.0%, showing the challenges in that market.
However, the regulatory landscape in the U.S. could change to the company's advantage, and it's seeing strong growth from Velo nicotine pouches.
The U.S. challenges alone may not be enough of a reason to sell the stock, especially since the all-important dividend remains safe, but investors should temper any growth expectations they had.
Before you buy stock in British American Tobacco, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and British American Tobacco wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $826,130!*
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.
See the 10 stocks »
*Stock Advisor returns as of October 7, 2024
Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool recommends British American Tobacco P.l.c. and recommends the following options: long January 2026 $40 calls on British American Tobacco and short January 2026 $40 puts on British American Tobacco. The Motley Fool has a disclosure policy.